Lived Experiences of Women Diagnosed With HPV Infection
Living Between Fear and Uncertainty: The Lived Experiences of Women Diagnosed With HPV Infection - A Phenomenological Study
This qualitative phenomenological study aims to explore the lived experiences of women diagnosed with human papillomavirus (HPV) infection. The study will examine women's emotional responses to the diagnosis, its perceived effects on daily life, sexual life and partner relationships, their experiences of disclosing the diagnosis, and their information and support needs. Eligible women diagnosed with HPV infection will participate in individual semi-structured interviews. The interview data will be analyzed thematically to identify common themes reflecting participants' experiences and perceptions.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This study is designed as a qualitative phenomenological study to gain an in-depth understanding of the lived experiences of women diagnosed with HPV infection. Participants will be adult women with a confirmed HPV diagnosis who meet the eligibility criteria and provide written informed consent.
Data will be collected through individual face-to-face semi-structured interviews. The interview guide explores participants' experiences from the time of HPV diagnosis, emotional responses, perceived effects on daily and sexual life, partner relationships and disclosure experiences, concerns regarding future health, experiences with healthcare professionals, and perceived information and support needs. Interviews are expected to last approximately 30-45 minutes and will be audio-recorded with participants' permission.
Data collection will continue until data saturation is achieved, with approximately 15-20 participants anticipated. Interview recordings will be transcribed and analyzed thematically. Participant identities will be protected through coding, and personally identifying information will not be included in the analysis or reporting of the findings.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Ahmet Demirci, MD
- Numero di telefono: +905418807091
- Email: ahmet.demirci@bilecik.edu.tr
Luoghi di studio
-
-
Bilecik
-
Bilecik, Bilecik, Turchia (Türkiye), 11230
- Reclutamento
- Bilecik Training and Research Hospital
-
Sub-investigatore:
- Aysun Acun, PhD
-
Contatto:
- Ahmet Demirci, MD
- Numero di telefono: +905418807091
- Email: ahmet.demirci@bilecik.edu.tr
-
Sub-investigatore:
- Büşra Küçüktürkmen, PhD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Adult women aged 18 years or older with a confirmed HPV infection who meet the eligibility criteria and voluntarily agree to participate in the study. Participants will be recruited among women evaluated at the study center and will undergo individual semi-structured interviews regarding their lived experiences following HPV diagnosis.
Descrizione
Inclusion Criteria:
- Confirmed diagnosis of HPV infection by HPV DNA testing
- Ability to communicate verbally in Turkish
- Willingness to participate in an individual semi-structured interview
- Provision of written informed consent
Exclusion Criteria:
- Inability to communicate adequately in Turkish
- Cognitive or communication difficulties that would prevent participation in the interview
- Refusal or withdrawal of informed consent
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: OTHER
- Prospettive temporali: PROSPECTIVE
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Women Diagnosed With HPV Infection
Adult women aged 18 years or older with a confirmed HPV infection who meet the eligibility criteria and provide written informed consent. Participants will take part in individual semi-structured interviews exploring their lived experiences following HPV diagnosis. |
Participants will take part in an individual face-to-face semi-structured interview exploring their lived experiences following HPV diagnosis, including emotional responses, daily and sexual life, partner relationships, disclosure experiences, future health concerns, experiences with healthcare professionals, and information and support needs. Interviews are expected to last approximately 30-45 minutes and will be audio-recorded with participants' permission. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Lived Experiences of Women Diagnosed With HPV Infection
Lasso di tempo: At least 4 weeks after HPV diagnosis, following the initial acute adjustment period, during a single 30-45-minute semi-structured interview.
|
Participants' lived experiences following HPV diagnosis will be explored through individual semi-structured interviews. Interview transcripts will be analyzed thematically to identify themes related to emotional responses, daily and sexual life, partner relationships, disclosure experiences, future health concerns, interactions with healthcare professionals, and information and support needs. |
At least 4 weeks after HPV diagnosis, following the initial acute adjustment period, during a single 30-45-minute semi-structured interview.
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Ahmet Demirci, Bilecik Seyh Edebali University Faculty of Medicine
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Malattie urogenitali
- Malattie genitali
- Processi patologici
- Attributi della malattia
- Infezioni
- Malattie virali
- Malattie trasmissibili
- Malattie sessualmente trasmissibili, virali
- Malattie trasmesse sessualmente
- Infezioni da virus del DNA
- Infezioni da virus tumorali
- Condizioni patologiche, segni e sintomi
- Infezioni da papillomavirus
Altri numeri di identificazione dello studio
- HPV-PHEN-2026-01
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Individual participant data will not be publicly shared due to the qualitative nature of the study and the potential risk of identifying participants from interview data. Data will be kept confidential and used only for the purposes of this study.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .